LatestQA
How to Reduce Human Error in Pharmaceutical Operations
Why retraining alone rarely works, and the practical controls that reduce human error in pharmaceutical manufacturing, packaging and documentation.
Pharmaceutical regulatory reference
GMP, validation and pharmacopoeial guidance explained clearly
Pharmaceutical Guideline turns dense regulatory source material — ICH, PIC/S, 21 CFR, Schedule M, USP and Ph. Eur. — into articles you can actually use, whether you are studying for your first QA role or running a sterile facility.
- in-depth articles
- 118in-depth articles
- subject areas
- 11subject areas
- publishing
- since 2020publishing
Fresh from the library
Recent articles
GeneralUnderstanding the 2026 EU Pharma Legislation Overhaul: Key Insights for Compliance Teams
The European Union is preparing for the most significant change in pharmaceutical regulation in over 20 years. On December 11, 2025, political agreement was reached on a new set of rules that will reshape how medicines for human use are developed, approved, and monitored across the EU. The final texts of a new regulation and directive were published in March 2026, marking a major overhaul of the EU pharma legislation framework.This update affects every stage of a medicine’s lifecycle, from early
Ensuring Pharmaceutical Data Integrity in Manufacturing
In pharmaceutical manufacturing, maintaining the accuracy and reliability of data is not just a regulatory requirement - it is a cornerstone of patient safety and product quality. I have seen firsthand how lapses in data integrity can lead to costly recalls, regulatory actions, and most importantly, risks to public health. That is why I want to share practical insights on how to ensure pharmaceutical data integrity throughout the manufacturing process.Data integrity means that all data generated
GeneralNavigating the Evolving Pharmaceutical Manufacturing Landscape in 2026
Sterile lab with shiny metal machinery, blue lighting, control panels, and empty glass vials on a conveyor. Modern and clean
Understanding Pharmaceutical Compliance Guidelines in the Pharmaceutical Industry
Compliance in the pharmaceutical industry is not just a regulatory requirement; it is the backbone of ensuring patient safety, product quality, and trust in healthcare. As someone deeply involved in pharmaceutical manufacturing and quality assurance, I understand how complex and critical compliance can be. This post aims to clarify what compliance means in this sector, why it matters, and how to navigate the often intricate landscape of pharmaceutical regulations.Pharmaceutical compliance guidel
Understanding Pharmaceutical Compliance Guidelines for Quality Assurance
In the pharmaceutical industry, quality assurance is not just a goal - it is a necessity. Ensuring that every product meets strict safety and efficacy standards requires a deep understanding of pharmaceutical compliance guidelines. These guidelines serve as the backbone for manufacturing processes, regulatory submissions, and overall product integrity. Today, I want to walk you through the essentials of these guidelines, explain their importance, and share practical insights on how to implement
Essential Pharmaceutical Compliance Guidelines Explained
Navigating the complex world of pharmaceutical compliance can feel overwhelming. As someone deeply involved in pharmaceutical manufacturing and quality assurance, I understand how critical it is to stay updated with the latest guidelines. These rules ensure that products are safe, effective, and meet regulatory standards worldwide. In this post, I will break down essential pharmaceutical compliance guidelines, explain their importance, and offer practical advice to help you maintain compliance i
Browse the library
Explore by subject
71 articles
QA
How to Reduce Human Error in Pharmaceutical Operations
Why retraining alone rarely works, and the practical controls that reduce human error in pharmaceutical manufacturing, packaging and documentation.
Deadline Dilemma: The Case for Extending Revised Schedule M to December 2026
As of January 2026, the Indian pharma sector faces a massive bottleneck: over 13,000 plants require inspection, yet only ~1,100 field inspectors are active. While the government has enforced Revised Schedule M, Laghu Udhyog Bharti is pushing for a vital extension until December 2026 to prevent the closure of thousands of MSMEs and ensure the continued supply of affordable medicine.
Enhancing Productivity and Quality in Pharmaceutical Industries
Improving productivity & quality is critical to ensuring efficient operations, regulatory compliance & the delivery of high-quality products
60 articles
QC
How to Reduce Human Error in Pharmaceutical Operations
Why retraining alone rarely works, and the practical controls that reduce human error in pharmaceutical manufacturing, packaging and documentation.
Enhancing Productivity and Quality in Pharmaceutical Industries
Improving productivity & quality is critical to ensuring efficient operations, regulatory compliance & the delivery of high-quality products
How to Utilize 5 WHY Analysis to Uncover Root Cause
5 Whys analysis is an essential tool for identifying the root causes of issues in the pharmaceutical industry
38 articles
Pharmacopoeia
Shutdown of European Pharmacopoeia 10th Edition
European Pharmacopoeia (Ph. Eur.) 10th Edition has been obsolete since 1 January 2023. all previous versions are no longer been accessible.
New paragraph on control of N-nitrosamines, Ph. Eur. revised General Monograph 2034 and 2619
Ph. Eur. Commission adopts revised general monographs 2034 and 2619 after inclusion of a new paragraph on control of N-nitrosamines
Pastes
Pastes are semisolid preparations of stiff consistency and contain a high percentage 20%–50% of finely dispersed solids. Pastes are intended for
36 articles
General
Understanding the 2026 EU Pharma Legislation Overhaul: Key Insights for Compliance Teams
The European Union is preparing for the most significant change in pharmaceutical regulation in over 20 years. On December 11, 2025, political agreement was reached on a new set of rules that will reshape how medicines for human use are developed, approved, and monitored across the EU. The final texts of a new regulation and directive were published in March 2026, marking a major overhaul of the EU pharma legislation framework.This update affects every stage of a medicine’s lifecycle, from early
Navigating the Evolving Pharmaceutical Manufacturing Landscape in 2026
Sterile lab with shiny metal machinery, blue lighting, control panels, and empty glass vials on a conveyor. Modern and clean
Deadline Dilemma: The Case for Extending Revised Schedule M to December 2026
As of January 2026, the Indian pharma sector faces a massive bottleneck: over 13,000 plants require inspection, yet only ~1,100 field inspectors are active. While the government has enforced Revised Schedule M, Laghu Udhyog Bharti is pushing for a vital extension until December 2026 to prevent the closure of thousands of MSMEs and ensure the continued supply of affordable medicine.
Popular topics
Browse by subject across all 28 main topics.
- Basic Learning for Fresher78
- Quality Assurance75
- Pharma Interview Tips64
- Quality Control61
- Interview Preparation53
- Pharmacopoeia46
- CGMP35
- GMP34
- Quality Management System33
- QMS31
- Pharma Learning29
- Engineering23
- FDA23
- Pharma Interview23
- Pharma Guideline20
- Manufacturing17
- B Pharm11
- Pharma11
- M Pharm10
- Drug9
- M Sc9
- Pharmaceutical Job9
- Pharma Job8
- Qualification8
- B Sc5
- pharmaceutical quality system (PQS)5
- Diploma4
- PIC/S4